In Vitro Validation of Antiviral Candidates
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract involves conducting laboratory testing to evaluate AI-generated compounds for their antiviral efficacy, cytotoxicity, and mechanisms of action specifically against filoviruses using cell-based assays. The work focuses on in vitro validation to identify promising antiviral candidates through rigorous biological assessments. The contract is a subcontract under the Department of Health and Human Services, specifically managed by the Biomedical Advanced Research and Development Authority (BARDA). The solicitation was posted on May 21, 2026, with a response deadline of July 17, 2026. It falls under the NAICS code 541990, which covers all other professional, scientific, and technical services, implying a scientific research and laboratory focus. While detailed location and point of contact information are not specified, the contract is clearly aimed at advancing the development of antiviral therapeutics against filoviruses, a group of viruses known for severe outbreaks, underscoring the public health importance of this research.
General Info
Agency
NAICS
Place of Performance
DCSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
